| Financial Year |
March 31 2023 |
| Monetary Funds |
57,013,600.08 |
| Held-for-trading Financial Assets |
128.03 |
| Notes Receivable |
33,294,488.93 |
| Accounts Receivable |
403,566,691.42 |
| Advances to Suppliers |
38,787,474.87 |
| Other Receivables |
7,522,513.33 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
356,347,058.34 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
8,587,364.40 |
| Total Current Assets |
1,043,255,867.25 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
2,197,124.60 |
| Investment Properties |
-- |
| Fixed Assetes |
438,660,770.94 |
| Under-construction Projects |
1,076,140.60 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
37,349,504.81 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
8,012,408.29 |
| Deferred Income Tax Assets |
16,062,178.74 |
| Other Non-Current Assets |
24,447,793.59 |
| Sub-Total of Non-Current Assets |
551,204,822.41 |
| Total Assets |
1,594,460,689.66 |
| Short-Term Loans |
263,856,130.56 |
| Trading Financial liabilities |
-- |
| Notes Payable |
224,743,247.67 |
| Accounts Payable |
186,886,949.56 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
11,248,314.59 |
| Taxes Payable |
1,944,674.72 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
7,383,340.84 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
9,365,865.78 |
| Other Current Liabilities |
22,393,876.21 |
| Sub-Total of Current Liabilities |
732,632,131.53 |
| Long-term Loans |
20,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,037,444.73 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
58,127,025.92 |
| Total Liabilities |
790,759,157.45 |
| Paid-In Capital(Or Share Stock) |
107,969,800.00 |
| Capital Surplus |
266,068,694.35 |
| Surplus Reserve |
62,130,526.35 |
| LESS:Treasury Stock |
12,798,063.00 |
| Undistributed Profits |
369,612,232.99 |
| Minority Stockholder's Interest |
10,718,341.52 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
792,983,190.69 |
| Owner's Equity（Stockholder's Equity） |
803,701,532.21 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,594,460,689.66 |
